Volume : 11, Issue : 09, September – 2024
Title:
PROBING PROBIOTICS: EXPLORING THEIR ROLE IN COSMETICS AND PERSONAL CARE INNOVATIONS
Authors :
Vinayak A. Katekar, Manasi M.Choudhari, Ashish N. Umale, Swati P. Deshmukh
Abstract :
Probiotics are gaining popularity and commercial viability. They are characterized as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.” But far too many of the goods on the market today that are marketed as probiotics don’t meet the qualifying requirements. The number of items categorized as probiotics has expanded in the cosmetics market in recent years. Probiotics have a number of potential uses in personal care products, particularly for skin, oral, and intimate care. However, appropriate regulation of labelling and marketing standards is still necessary to ensure that consumers are, in fact, buying probiotic goods. This research examines probiotics’ present market, regulatory issues, and possible uses in the personal care sector. Probiotics, defined as live microorganisms conferring health benefits when administered adequately, have gained substantial popularity and commercial presence. However, concerns arise as many products marketed as probiotics do not meet these qualifying standards. In recent years, the cosmetics market has witnessed a notable increase in items labelled as probiotics, despite uncertainties regarding their efficacy and adherence to regulatory criteria. This study investigates the current state of probiotics in the market, focusing on regulatory challenges and potential applications in the personal care sector, specifically in skin, oral, and intimate care products. Probiotics offer promising opportunities due to their purported beneficial effects, yet ensuring accurate labelling and marketing practices remains paramount. Effective regulation is essential to validate the probiotic content of products and to maintain consumer confidence. Key findings underscore the necessity for rigorous standards that verify the presence and efficacy of probiotics in personal care goods. Such measures are crucial not only for consumer protection but also for fostering transparency and credibility within the industry. By addressing these regulatory issues, this research aims to contribute to a clearer understanding of probiotics’ role in personal care and to advocate for policies that uphold product integrity and consumer trust in the marketplace.
Keywords: probiotics; cosmetics; skin; personal care; intimate care
Cite This Article:
Please cite this article in press Vinayak A. Katekar et al., Probing Probiotics: Exploring Their Role In Cosmetics And Personal Care Innovations, Indo Am. J. P. Sci, 2024; 11 (09).
Number of Downloads : 10
References:
1. US Food and Drug Administration. Cosmetics Overview [Internet]. Available from: https://www.fda.gov/industry/regulated-products/cosmetics-overview#cosmetic (accessed 2020 Nov 15).
2. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–14.
3. Probiotic Cosmetic Products Market Forecast, Trend Analysis and Competition Tracking-Global Market Insights 2020 to 2030 [Internet]. Available from: https://www.futuremarketinsights.com/reports/probiotic-cosmetic-products-market (accessed 2020).
4. Ulta Beauty [Internet]. Available from: https://www.ulta.com/ (accessed 2021 Feb 19).
5. Sephora [Internet]. Available from: https://www.sephora.com (accessed 2021 Feb 19).
6. Matts PJ. New insights into skin appearance and measurement. J Invest Dermatol Symp Proc. 2008;13:6–9.
7. Guéniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V, et al. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp Dermatol. 2010;19:1–8.
8. Klein G, Schanstra JP, Hoffmann J, Mischak H, Siwy J, Zimmermann K. Proteomics as a quality control tool of pharmaceutical probiotic bacterial lysate products. PLoS One. 2013;8.
9. Villa E, Garelli V, Braido F, Melioli G, Canonica GW. May we strengthen the human natural defenses with bacterial lysates? World Allergy Organ J. 2010;3–23.
10. Sultana R, McBain AJ, O’Neill CA. Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates. Appl Environ Microbiol. 2013;79:4887–94.
11. Mokrozub VV, Lazarenko LM, Sichel LM, Babenko LP, Lytvyn PM, Demchenko OM, et al. The role of beneficial bacteria wall elasticity in regulating innate immune response. EPMA J. 2015;6:13.
12. Mohammedsaeed W, Cruickshank S, McBain AJ, O’Neill CA. Lactobacillus rhamnosus GG lysate increases re-epithelialization of keratinocyte scratch assays by promoting migration. Sci Rep. 2015;5:16147.
13. Ankrah NYD, May AL, Middleton JL, Jones DR, Hadden MK, Gooding JR, et al. Phage infection of an environmentally relevant marine bacterium alters host metabolism and lysate composition. ISME J. 2014;8:1089–100.
14. Genova E, Pelin M, Decorti G, Stocco G, Sergo V, Ventura A, et al. SERS of cells: What can we learn from cell lysates? Anal Chim Acta. 2018;1005:93–100.
15. Navarro-López V, Martínez-Andrés A, Ramírez-Boscá A, Ruzafa-Costas B, Núñez-Delegido E, Carrión-Gutiérrez MA, et al. Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: A randomized controlled clinical trial. ActaDermVenereol. 2019;99:1078–84.
16. Yu Y, Dunaway S, Champer J, Kim J, Alikhan A. Changing our microbiome: Probiotics in dermatology. Br J Dermatol. 2020;182:39–46.
17. Korpela K, Salonen A, Vepsäläinen O, Suomalainen M, Kolmeder C, Varjosalo M, et al. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarian-born infants. Microbiome. 2018;6:182.
18. Sharma D, Kober MM, Bowe WP. Anti-aging effects of probiotics. J Drugs Dermatol. 2016;15:9–12.
19. Jung GW, Tse JE, Guiha I, Rao J. Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J Cutan Med Surg. 2013;17:114–22.
20. Knackstedt R, Knackstedt T, Gatherwright J. The role of topical probiotics in skin conditions: A systematic review of animal and human studies and implications for future therapies. Exp Dermatol. 2020;29:15–21.
21. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet. 2003;361:1869–71.
22. Isolauri E, Kalliomaki M, Laitinen K, Salminen S. Modulation of the maturing gut barrier and microbiota: A novel target in allergic disease. Curr Pharm Des. 2008;14:1368–75.
23. Hubálek Z. Protectants used in the cryopreservation of microorganisms. Cryobiology. 2003;46:205–29.
24. Morgan CA, Herman N, White PA, Vesey G. Preservation of microorganisms by drying; a review. J Microbiol Methods. 2006;66:183–203.
25. Yao M, Xie J, Du H, McClements DJ, Xiao H, Li L. Progress in microencapsulation of probiotics: A review. Compr Rev Food Sci Food Saf. 2020;19:857–74.
26. Puebla-Barragan S, Reid G. Forty-five-year evolution of probiotic therapy. Microb Cell. 2019;6:184–96.
27. Government of Canada. Questions and Answers on Probiotics [Internet]. Available from: https://www.canada.ca/en/health-canada/services/food-nutrition/food-labelling/health-claims/questions-answers-probiotics.html (accessed on 20 November 2020).
28. US Food and Drug Administration. Methods for cosmetics. In: Bacteriological Analytical Manual.
29. Salminen S. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol.
30. Marco ML, Sanders ME, Gänzle M, Arrieta MC, Cotter PD, De Vuyst L, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods.
31. Chojnacka K. Fermentation products. In: Pohorecki R, Bridgwater J, Molzahn M, Gani R, Gallegos C, editors. Chemical Engineering and Chemical Process Technology-Volume V: Chemical Engineering Education and Main Products. London, UK: Eolss Publishers Co. Ltd.; 2010. Volume 5.
32. Bruce AW, Chadwick P, Hassan A, VanCott GF. Recurrent urethritis in women. Can Med Assoc J. 1973;108:973–6.
33. Bruce AW, Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol. 1988;34:339–43.
34. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001;30:49–52.
35. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52:1212–7.
36. Verdenelli MC, Cecchini C, Coman MM, Silvi S, Orpianesi C, Coata G, et al. Impact of probiotic SYNBIO® administered by vaginal suppositories in promoting vaginal health of apparently healthy women. CurrMicrobiol. 2016;73:483–90.
37. Rossi A, Rossi T, Bertini M, Caccia G. The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24 months. Arch Gynecol Obstet. 2010;281:1065–9.
38. Petricevic L, Witt A. The role of Lactobacillus caseirhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. Gen Gynaecol. 2008:1369–74.
39. Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C, et al. The burden of bacterial vaginosis: Women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS ONE. 2013;8.
40. McMillan A, Rulisa S, Sumarah M, Macklaim JM, Renaud J, Bisanz JE, et al. A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women. Sci Rep. 2015;5:1–14.
41. Puebla-Barragan S, Renaud J, Sumarah M, Reid G. Malodorous biogenic amines in Escherichia coli-caused urinary tract infections in women—a metabolomics approach. Sci Rep. 2020;10:9703.
42. Donders G, Bellen G, Oerlemans E, Claes I, Ruban K, Henkens T, et al. The use of 3 selected lactobacillary strains in vaginal probiotic gel for the treatment of acute Candida vaginitis: A proof-of-concept study. Eur J ClinMicrobiol Infect Dis. 2020;39:1551–8.
43. Iwamoto T, Suzuki N, Tanabe K, Takeshita T, Hirofuji T. Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: An open-label pilot trial. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2010;110:201–8. 45.
44. Masdea L, Kulik E, Hauser-Gerspach I, Ramseier A, Filippi A, Waltimo T, et al. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol. 2012;57:1041–7. doi: 10.1016/j.archoralbio.2012.02.011.
45. Lebeer S, Oerlemans E, Claes I, Wuyts S, Henkens T, Spacova I, et al. Topical cream with live lactobacilli modulates the skin microbiome and reduce acne symptoms. bioRxiv. 2018.
46. Vieira AT, et al. Influence of Oral and Gut Microbiota in the Health of Menopausal Women. Front Microbiol. 2017;8:1884.
47. Guéniche A, et al. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut Microbes. 2010;1(4):299-306.
48. Kim HS, et al. A novel cosmetic strategy based on lactic acid bacteria-produced metabolites. PLoS One. 2014;9(12)
49. Jensen GS, et al. A Double-Blind Placebo-Controlled Clinical Study Evaluating the Effectiveness of a Probiotic and Prebiotic Skin Care Regimen. J Clin Aesthet Dermatol. 2021;14(5):28-32.
50. Fore J, et al. Probiotics, prebiotics and the gut microbiota. Transl Res. 2010;160(4):289-95